Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Galster

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Radiologe|July 9, 2020
[Artificial intelligence-based algorithms : Decision-making support for computed tomography of the chest]Panagiota Manava, Marco Galster, Henrik Heinen, et al.
Investigative Radiology|August 4, 2022
Optimized Camera-Based Patient Positioning in CT: Impact on Radiation ExposurePanagiota Manava, Marco Galster, Josefin Ammon, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid BiopsyMarkus Falk, Eva Willing, Stefanie Schmidt, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case ReportMarkus Falk, Stefanie Schatz, Fabian P M Reich, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Radiologe|July 9, 2020
[Artificial intelligence-based algorithms : Decision-making support for computed tomography of the chest]Panagiota Manava, Marco Galster, Henrik Heinen, et al.
Investigative Radiology|August 4, 2022
Optimized Camera-Based Patient Positioning in CT: Impact on Radiation ExposurePanagiota Manava, Marco Galster, Josefin Ammon, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid BiopsyMarkus Falk, Eva Willing, Stefanie Schmidt, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case ReportMarkus Falk, Stefanie Schatz, Fabian P M Reich, et al.
Pageof 1